 Brian Varisco
Concepts (187)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung | 16 | 2021 | 490 | 3.700 |
Why?
| | Pulmonary Emphysema | 3 | 2024 | 24 | 2.450 |
Why?
| | Emphysema | 3 | 2024 | 15 | 2.440 |
Why?
| | Pancreatic Elastase | 6 | 2024 | 15 | 2.220 |
Why?
| | alpha 1-Antitrypsin | 3 | 2019 | 14 | 1.430 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 2018 | 180 | 1.050 |
Why?
| | Trachea | 4 | 2021 | 52 | 1.030 |
Why?
| | Fibroblasts | 6 | 2021 | 351 | 0.980 |
Why?
| | Pulmonary Alveoli | 2 | 2014 | 19 | 0.940 |
Why?
| | Stress, Mechanical | 2 | 2021 | 92 | 0.890 |
Why?
| | Fetus | 3 | 2021 | 216 | 0.880 |
Why?
| | Acute Lung Injury | 1 | 2023 | 20 | 0.870 |
Why?
| | Mice | 17 | 2024 | 5759 | 0.870 |
Why?
| | Lung Injury | 1 | 2022 | 25 | 0.820 |
Why?
| | Organoids | 1 | 2021 | 40 | 0.780 |
Why?
| | High-Frequency Jet Ventilation | 1 | 2021 | 6 | 0.760 |
Why?
| | Animals | 20 | 2024 | 13246 | 0.740 |
Why?
| | Scoliosis | 1 | 2020 | 60 | 0.690 |
Why?
| | Mice, Inbred C57BL | 9 | 2021 | 1819 | 0.690 |
Why?
| | DNA-Binding Proteins | 1 | 2022 | 428 | 0.690 |
Why?
| | Spinal Fusion | 1 | 2020 | 70 | 0.690 |
Why?
| | Respiratory Insufficiency | 1 | 2021 | 113 | 0.680 |
Why?
| | alpha 1-Antitrypsin Deficiency | 1 | 2019 | 3 | 0.670 |
Why?
| | Mechanotransduction, Cellular | 2 | 2021 | 36 | 0.670 |
Why?
| | Oligonucleotides, Antisense | 1 | 2019 | 28 | 0.670 |
Why?
| | Body Fluids | 1 | 2018 | 20 | 0.640 |
Why?
| | Elastin | 4 | 2024 | 23 | 0.640 |
Why?
| | Sheep | 1 | 2018 | 90 | 0.630 |
Why?
| | Airway Obstruction | 1 | 2018 | 47 | 0.620 |
Why?
| | Chymases | 2 | 2015 | 3 | 0.610 |
Why?
| | Sex Characteristics | 1 | 2019 | 191 | 0.590 |
Why?
| | Child | 11 | 2024 | 6851 | 0.560 |
Why?
| | Morphogenesis | 1 | 2015 | 16 | 0.490 |
Why?
| | Peritoneal Cavity | 2 | 2016 | 8 | 0.490 |
Why?
| | Pneumonectomy | 1 | 2014 | 30 | 0.490 |
Why?
| | Disease Models, Animal | 5 | 2023 | 1458 | 0.480 |
Why?
| | Sepsis | 3 | 2023 | 221 | 0.480 |
Why?
| | Mitogen-Activated Protein Kinase 8 | 1 | 2014 | 6 | 0.470 |
Why?
| | Elasticity | 1 | 2014 | 20 | 0.470 |
Why?
| | Cell Differentiation | 3 | 2023 | 650 | 0.460 |
Why?
| | Models, Animal | 3 | 2021 | 232 | 0.440 |
Why?
| | Humans | 20 | 2024 | 50208 | 0.410 |
Why?
| | Intensive Care Units, Pediatric | 3 | 2024 | 167 | 0.410 |
Why?
| | Swine | 2 | 2024 | 396 | 0.410 |
Why?
| | PPAR gamma | 1 | 2012 | 73 | 0.380 |
Why?
| | Drowning | 1 | 2010 | 3 | 0.370 |
Why?
| | Central Nervous System Diseases | 1 | 2010 | 27 | 0.360 |
Why?
| | Fetoscopy | 2 | 2021 | 2 | 0.350 |
Why?
| | Central Nervous System | 1 | 2010 | 85 | 0.340 |
Why?
| | Recovery of Function | 1 | 2010 | 187 | 0.340 |
Why?
| | Echinocandins | 1 | 2009 | 64 | 0.330 |
Why?
| | Candidiasis | 1 | 2009 | 114 | 0.320 |
Why?
| | Mice, Transgenic | 3 | 2014 | 550 | 0.320 |
Why?
| | Multiple Organ Failure | 2 | 2024 | 47 | 0.290 |
Why?
| | Embryo, Mammalian | 3 | 2021 | 66 | 0.250 |
Why?
| | Mice, Knockout | 3 | 2018 | 846 | 0.250 |
Why?
| | Carcinoid Tumor | 1 | 2004 | 14 | 0.240 |
Why?
| | Appendiceal Neoplasms | 1 | 2004 | 7 | 0.240 |
Why?
| | Colectomy | 1 | 2004 | 28 | 0.240 |
Why?
| | Appendectomy | 1 | 2004 | 33 | 0.240 |
Why?
| | Adolescent | 4 | 2024 | 6390 | 0.230 |
Why?
| | Critical Illness | 2 | 2023 | 288 | 0.230 |
Why?
| | Cells, Cultured | 4 | 2016 | 1581 | 0.230 |
Why?
| | Keratin-8 | 1 | 2023 | 3 | 0.230 |
Why?
| | Female | 11 | 2024 | 26635 | 0.230 |
Why?
| | Enzyme Activation | 2 | 2015 | 275 | 0.230 |
Why?
| | Idiopathic Pulmonary Fibrosis | 1 | 2023 | 9 | 0.230 |
Why?
| | Acceleration | 1 | 2023 | 8 | 0.230 |
Why?
| | Mesoderm | 2 | 2021 | 27 | 0.220 |
Why?
| | Thorax | 1 | 2023 | 16 | 0.220 |
Why?
| | Respiratory System | 1 | 2023 | 26 | 0.220 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2023 | 89 | 0.220 |
Why?
| | Animals, Newborn | 2 | 2014 | 368 | 0.210 |
Why?
| | Nose | 1 | 2022 | 31 | 0.200 |
Why?
| | Inflammation | 2 | 2024 | 604 | 0.200 |
Why?
| | Repressor Proteins | 1 | 2022 | 153 | 0.190 |
Why?
| | Respiration, Artificial | 1 | 2024 | 274 | 0.190 |
Why?
| | NF-kappa B | 1 | 2023 | 315 | 0.190 |
Why?
| | Follow-Up Studies | 2 | 2020 | 2190 | 0.190 |
Why?
| | Xenon Isotopes | 1 | 2020 | 1 | 0.190 |
Why?
| | Male | 9 | 2024 | 25399 | 0.190 |
Why?
| | Treatment Outcome | 4 | 2020 | 5155 | 0.180 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2020 | 124 | 0.170 |
Why?
| | Gene Knockdown Techniques | 1 | 2019 | 106 | 0.160 |
Why?
| | Aging | 1 | 2024 | 688 | 0.160 |
Why?
| | Tubulin | 1 | 2018 | 23 | 0.160 |
Why?
| | Prospective Studies | 5 | 2024 | 2379 | 0.160 |
Why?
| | Models, Biological | 1 | 2021 | 723 | 0.160 |
Why?
| | Transcriptome | 1 | 2020 | 320 | 0.160 |
Why?
| | Oxygen | 1 | 2021 | 325 | 0.150 |
Why?
| | Child, Preschool | 5 | 2024 | 3883 | 0.150 |
Why?
| | Phenotype | 1 | 2020 | 733 | 0.150 |
Why?
| | Case-Control Studies | 1 | 2020 | 1126 | 0.150 |
Why?
| | Prenatal Care | 1 | 2018 | 109 | 0.140 |
Why?
| | Gene Expression Regulation | 1 | 2021 | 979 | 0.140 |
Why?
| | Matrix Metalloproteinase 8 | 1 | 2016 | 8 | 0.140 |
Why?
| | Neutrophil Infiltration | 1 | 2016 | 26 | 0.140 |
Why?
| | Capillary Permeability | 1 | 2016 | 35 | 0.140 |
Why?
| | Zinc | 1 | 2016 | 51 | 0.140 |
Why?
| | Reperfusion Injury | 1 | 2016 | 87 | 0.130 |
Why?
| | Neutrophils | 1 | 2016 | 148 | 0.130 |
Why?
| | Proteomics | 1 | 2018 | 330 | 0.130 |
Why?
| | Anti-Inflammatory Agents | 1 | 2016 | 160 | 0.130 |
Why?
| | Intestines | 1 | 2016 | 168 | 0.130 |
Why?
| | Elastic Modulus | 1 | 2015 | 11 | 0.130 |
Why?
| | Tensile Strength | 1 | 2015 | 28 | 0.120 |
Why?
| | Tissue Distribution | 1 | 2015 | 163 | 0.120 |
Why?
| | Pregnancy | 2 | 2021 | 2604 | 0.120 |
Why?
| | Amino Acid Sequence | 1 | 2015 | 586 | 0.120 |
Why?
| | Regeneration | 1 | 2014 | 72 | 0.120 |
Why?
| | Gene Expression Profiling | 1 | 2018 | 1037 | 0.110 |
Why?
| | Magnetic Resonance Imaging | 1 | 2020 | 1541 | 0.110 |
Why?
| | Liver | 1 | 2019 | 1116 | 0.110 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2013 | 136 | 0.100 |
Why?
| | Infant | 4 | 2024 | 3563 | 0.100 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2013 | 143 | 0.100 |
Why?
| | Esterification | 1 | 2012 | 6 | 0.100 |
Why?
| | Prognosis | 3 | 2024 | 1954 | 0.090 |
Why?
| | Kidney | 1 | 2015 | 672 | 0.090 |
Why?
| | Young Adult | 1 | 2020 | 3981 | 0.090 |
Why?
| | Shock, Septic | 1 | 2011 | 78 | 0.090 |
Why?
| | Pulmonary Surfactants | 1 | 2010 | 18 | 0.090 |
Why?
| | Hydroxamic Acids | 1 | 2010 | 38 | 0.090 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2010 | 56 | 0.090 |
Why?
| | Tumor Suppressor Proteins | 1 | 2010 | 128 | 0.090 |
Why?
| | Amphotericin B | 1 | 2009 | 110 | 0.080 |
Why?
| | Protein Processing, Post-Translational | 1 | 2010 | 171 | 0.080 |
Why?
| | Risk Assessment | 2 | 2024 | 1262 | 0.080 |
Why?
| | Cardiopulmonary Resuscitation | 1 | 2010 | 135 | 0.080 |
Why?
| | Drug Therapy, Combination | 1 | 2009 | 381 | 0.080 |
Why?
| | Histones | 1 | 2010 | 313 | 0.080 |
Why?
| | Cytokines | 2 | 2024 | 613 | 0.070 |
Why?
| | Signal Transduction | 1 | 2012 | 1622 | 0.060 |
Why?
| | ROC Curve | 1 | 2024 | 232 | 0.060 |
Why?
| | Angiopoietin-2 | 1 | 2023 | 15 | 0.060 |
Why?
| | Developing Countries | 1 | 2023 | 49 | 0.050 |
Why?
| | Odds Ratio | 1 | 2004 | 546 | 0.050 |
Why?
| | Infant, Newborn | 1 | 2009 | 2766 | 0.050 |
Why?
| | Epithelial Cells | 1 | 2023 | 207 | 0.050 |
Why?
| | Longitudinal Studies | 1 | 2024 | 695 | 0.050 |
Why?
| | Pennsylvania | 1 | 2020 | 30 | 0.050 |
Why?
| | Helium | 1 | 2020 | 2 | 0.050 |
Why?
| | Diffusion | 1 | 2020 | 15 | 0.050 |
Why?
| | Bayes Theorem | 1 | 2020 | 109 | 0.040 |
Why?
| | Reproducibility of Results | 1 | 2023 | 1185 | 0.040 |
Why?
| | Logistic Models | 1 | 2020 | 889 | 0.040 |
Why?
| | Pediatrics | 1 | 2020 | 279 | 0.040 |
Why?
| | Peroxidase | 1 | 2016 | 15 | 0.040 |
Why?
| | Phagocytosis | 1 | 2016 | 49 | 0.040 |
Why?
| | Aged, 80 and over | 1 | 2004 | 3154 | 0.040 |
Why?
| | Claudin-3 | 1 | 2016 | 5 | 0.030 |
Why?
| | Tight Junction Proteins | 1 | 2016 | 7 | 0.030 |
Why?
| | Immunomodulation | 1 | 2016 | 37 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2018 | 380 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2016 | 113 | 0.030 |
Why?
| | Cell Movement | 1 | 2016 | 249 | 0.030 |
Why?
| | SOX9 Transcription Factor | 1 | 2013 | 3 | 0.030 |
Why?
| | Receptor, TIE-2 | 1 | 2013 | 16 | 0.030 |
Why?
| | Epithelium | 1 | 2013 | 65 | 0.030 |
Why?
| | Embryonic Development | 1 | 2013 | 17 | 0.030 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 2013 | 51 | 0.030 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2013 | 53 | 0.030 |
Why?
| | Wnt Proteins | 1 | 2013 | 100 | 0.030 |
Why?
| | Cell Death | 1 | 2013 | 182 | 0.030 |
Why?
| | Wnt Signaling Pathway | 1 | 2013 | 92 | 0.030 |
Why?
| | Retrospective Studies | 1 | 2004 | 6134 | 0.030 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2013 | 202 | 0.030 |
Why?
| | Protein Array Analysis | 1 | 2011 | 23 | 0.020 |
Why?
| | Gene Deletion | 1 | 2013 | 270 | 0.020 |
Why?
| | Endothelium, Vascular | 1 | 2013 | 254 | 0.020 |
Why?
| | Aged | 1 | 2004 | 9405 | 0.020 |
Why?
| | Pulmonary Fibrosis | 1 | 2010 | 18 | 0.020 |
Why?
| | Methylation | 1 | 2010 | 123 | 0.020 |
Why?
| | Gene Silencing | 1 | 2010 | 118 | 0.020 |
Why?
| | CpG Islands | 1 | 2010 | 107 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2013 | 978 | 0.020 |
Why?
| | Middle Aged | 1 | 2004 | 12206 | 0.020 |
Why?
| | Gene Expression | 1 | 2011 | 609 | 0.020 |
Why?
| | Adult | 1 | 2004 | 13324 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2011 | 951 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2010 | 475 | 0.020 |
Why?
| | Epigenesis, Genetic | 1 | 2010 | 378 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2010 | 1378 | 0.020 |
Why?
| | DNA Methylation | 1 | 2010 | 550 | 0.020 |
Why?
| | Time Factors | 1 | 2010 | 2922 | 0.010 |
Why?
| | Rats | 1 | 2010 | 3299 | 0.010 |
Why?
| | Risk Factors | 1 | 2011 | 3629 | 0.010 |
Why?
|
|
Varisco's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|